Global Preclinical In-vivo Imaging Market Growth (Status and Outlook) 2019-2024
According to this study, over the next five years the Preclinical In-vivo Imaging market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Preclinical In-vivo Imaging business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Preclinical In-vivo Imaging market by product type, application, key companies and key regions.
This study considers the Preclinical In-vivo Imaging value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Optical Imaging Systems
Micro-Ultrasound Systems
Preclinical Nuclear Imaging Systems
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Research & Development
Drug Discovery
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bruker
Siemens
PerkinElmer
Fujifilm VisualSonics
TriFoil Imaging
MILabs
Mediso
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Preclinical In-vivo Imaging market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Preclinical In-vivo Imaging market by identifying its various subsegments.
Focuses on the key global Preclinical In-vivo Imaging players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Preclinical In-vivo Imaging with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Preclinical In-vivo Imaging submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Preclinical In-vivo Imaging Market Growth (Status and Outlook) 2019-2024
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Preclinical In-vivo Imaging Market Size 2014-2024
2.1.2 Preclinical In-vivo Imaging Market Size CAGR by Region
2.2 Preclinical In-vivo Imaging Segment by Type
2.2.1 Optical Imaging Systems
2.2.2 Optical Imaging Systems
2.2.3 Preclinical Nuclear Imaging Systems
2.2.4 Other
2.3 Preclinical In-vivo Imaging Market Size by Type
2.3.1 Global Preclinical In-vivo Imaging Market Size Market Share by Type (2014-2019)
2.3.2 Global Preclinical In-vivo Imaging Market Size Growth Rate by Type (2014-2019)
2.4 Preclinical In-vivo Imaging Segment by Application
2.4.1 Research & Development
2.4.2 Drug Discovery
2.5 Preclinical In-vivo Imaging Market Size by Application
2.5.1 Global Preclinical In-vivo Imaging Market Size Market Share by Application (2014-2019)
2.5.2 Global Preclinical In-vivo Imaging Market Size Growth Rate by Application (2014-2019)
3 Global Preclinical In-vivo Imaging by Players
3.1 Global Preclinical In-vivo Imaging Market Size Market Share by Players
3.1.1 Global Preclinical In-vivo Imaging Market Size by Players (2017-2019)
3.1.2 Global Preclinical In-vivo Imaging Market Size Market Share by Players (2017-2019)
3.2 Global Preclinical In-vivo Imaging Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Preclinical In-vivo Imaging by Regions
4.1 Preclinical In-vivo Imaging Market Size by Regions
4.2 Americas Preclinical In-vivo Imaging Market Size Growth
4.3 APAC Preclinical In-vivo Imaging Market Size Growth
4.4 Europe Preclinical In-vivo Imaging Market Size Growth
4.5 Middle East & Africa Preclinical In-vivo Imaging Market Size Growth
5 Americas
5.1 Americas Preclinical In-vivo Imaging Market Size by Countries
5.2 Americas Preclinical In-vivo Imaging Market Size by Type
5.3 Americas Preclinical In-vivo Imaging Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Preclinical In-vivo Imaging Market Size by Countries
6.2 APAC Preclinical In-vivo Imaging Market Size by Type
6.3 APAC Preclinical In-vivo Imaging Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Preclinical In-vivo Imaging by Countries
7.2 Europe Preclinical In-vivo Imaging Market Size by Type
7.3 Europe Preclinical In-vivo Imaging Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Preclinical In-vivo Imaging by Countries
8.2 Middle East & Africa Preclinical In-vivo Imaging Market Size by Type
8.3 Middle East & Africa Preclinical In-vivo Imaging Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Preclinical In-vivo Imaging Market Forecast
10.1 Global Preclinical In-vivo Imaging Market Size Forecast (2019-2024)
10.2 Global Preclinical In-vivo Imaging Forecast by Regions
10.2.1 Global Preclinical In-vivo Imaging Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Preclinical In-vivo Imaging Forecast by Type
10.8 Global Preclinical In-vivo Imaging Forecast by Application
11 Key Players Analysis
11.1 Bruker
11.1.1 Company Details
11.1.2 Preclinical In-vivo Imaging Product Offered
11.1.3 Bruker Preclinical In-vivo Imaging Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Bruker News
11.2 Siemens
11.2.1 Company Details
11.2.2 Preclinical In-vivo Imaging Product Offered
11.2.3 Siemens Preclinical In-vivo Imaging Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Siemens News
11.3 PerkinElmer
11.3.1 Company Details
11.3.2 Preclinical In-vivo Imaging Product Offered
11.3.3 PerkinElmer Preclinical In-vivo Imaging Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 PerkinElmer News
11.4 Fujifilm VisualSonics
11.4.1 Company Details
11.4.2 Preclinical In-vivo Imaging Product Offered
11.4.3 Fujifilm VisualSonics Preclinical In-vivo Imaging Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Fujifilm VisualSonics News
11.5 TriFoil Imaging
11.5.1 Company Details
11.5.2 Preclinical In-vivo Imaging Product Offered
11.5.3 TriFoil Imaging Preclinical In-vivo Imaging Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 TriFoil Imaging News
11.6 MILabs
11.6.1 Company Details
11.6.2 Preclinical In-vivo Imaging Product Offered
11.6.3 MILabs Preclinical In-vivo Imaging Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 MILabs News
11.7 Mediso
11.7.1 Company Details
11.7.2 Preclinical In-vivo Imaging Product Offered
11.7.3 Mediso Preclinical In-vivo Imaging Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Mediso News
...
12 Research Findings and Conclusion
Tables and Figures
Reason to Buy
- Current and future of Service & Software Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Service & Software Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets